Author Archives: Chandra Ganegoda

Importation of UK – Labelled ERWINASE for Injection to provide continued patient access to ERWINASE Injection

July 28, 2023 Audience Healthcare professions (medical oncologists, hematologists, oncology nurses, pharmacists), chiefs of medicines in hospitals, hospital pharmacy chiefs, and cancer clinics. Download the full article (English)

Bacitracin HPRC HEALTH CANADA APPROVED

Important Safety Information Bacitracin for Injection (50,000 IU p er vial) – Risk of Nephrotoxicity and Anaphylactic Reactions 2020/12/21 Audience Healthcare professionals including pediatricians, infectious disease specialists, surgeons, critical care physicians, emergency physicians, pharmacists, nurses, and intensive care unit (ICU) and emergency room (ER) medical staff. Key messages Serious cases of nephrotoxicity and hypersensitivity, including […]